Lewis J, Snyder M, Hyatt-Knorr H. Marking 15 years of the genetic and rare diseases information center. Transl Sci Rare Dis. 2017;2(1–2):77–88.

PubMed  PubMed Central  Google Scholar 

Zheng X, Tang Q, Ren L, Liu J, Li W, Fu W, et al. A narrative review of research progress on drug therapies for glioblastoma multiforme. Ann Transl Med. 2021;9(11):943.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fisher JP, Adamson DC. Current FDA-approved therapies for high-grade malignant gliomas. Biomedicines. 2021. https://doi.org/10.3390/biomedicines9030324.

Article  PubMed  PubMed Central  Google Scholar 

van den Berg S, de Visser S, Leufkens HGM, Hollak CEM. Drug repurposing for rare diseases: a role for academia. Front Pharmacol. 2021;12: 746987.

Article  PubMed  PubMed Central  Google Scholar 

Roessler HI, Knoers N, van Haelst MM, van Haaften G. Drug repurposing for rare diseases. Trends Pharmacol Sci. 2021;42(4):255–67.

Article  PubMed  CAS  Google Scholar 

Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discovery. 2004;3(8):673–83.

Article  PubMed  CAS  Google Scholar 

Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discovery. 2019;18(1):41–58.

Article  PubMed  CAS  Google Scholar 

Gordon LB, Massaro J, D’Agostino RB, Campbell SE, Brazier J, Brown WT, et al. Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome. Circulation. 2014;130(1):27–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kuemmerle-Deschner JB, Wittkowski H, Tyrrell PN, Koetter I, Lohse P, Ummenhofer K, et al. Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens. Arthritis Res Ther. 2013;15(3):R64.

Article  PubMed  PubMed Central  CAS  Google Scholar 

He H, Duo H, Hao Y, Zhang X, Zhou X, Zeng Y, et al. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications. Comput Biol Med. 2023;155: 106671.

Article  PubMed  CAS  Google Scholar 

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–35.

Article  PubMed  CAS  Google Scholar 

Stathias VTJ, Koleti A, Vidovic D, Cooper D, Fazel-Najafabadi M, Pilarczyk M, Terryn R, Chung C, Umeano A, Clarke DJB, Lachmann A, Evangelista JE, Ma’ayan A, Medvedovic M, Schurer SC. LINCS Data Portal 2.0: next generation access point for perturbation-response signatures. Nucleic Acids Res. 2019. https://doi.org/10.1093/nar/gkz1023.

Article  PubMed  PubMed Central  Google Scholar 

Pilarczyk M, Fazel-Najafabadi M, Kouril M, Shamsaei B, Vasiliauskas J, Niu W, et al. Connecting omics signatures and revealing biological mechanisms with iLINCS. Nat Commun. 2022;13(1):4678.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rabben H-L, Andersen GT, Ianevski A, Olsen MK, Kainov D, Grønbech JE, et al. Computational drug repositioning and experimental validation of ivermectin in treatment of gastric cancer. Front Pharmacol. 2021;12: 625991.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen B, Ma L, Paik H, Sirota M, Wei W, Chua M-S, et al. Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat Commun. 2017;8(1):16022.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao Y, Chen X, Chen J, Qi X. Decoding connectivity Map-based drug repurposing for oncotherapy. Brief Bioinform. 2023. https://doi.org/10.1093/bib/bbad142.

Article  PubMed  PubMed Central  Google Scholar 

Shukla R, Henkel ND, Alganem K, Hamoud A-R, Reigle J, Alnafisah RS, et al. Signature-based approaches for informed drug repurposing: targeting CNS disorders. Neuropsychopharmacology. 2021;46(1):116–30.

Article  PubMed  Google Scholar 

Lau A, So H-C. Turning genome-wide association study findings into opportunities for drug repositioning. Comput Struct Biotechnol J. 2020;18:1639–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao Z, Zhang K-N, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients. Gen Prot Bioinform. 2021;19(1):1–12.

Article  CAS  Google Scholar 

Buser DP, Ritz M-F, Moes S, Tostado C, Frank S, Spiess M, et al. Quantitative proteomics reveals reduction of endocytic machinery components in gliomas. EBioMedicine. 2019;46:32–41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pearson KLIII. On lines and planes of closest fit to systems of points in space. London Edinburghand Dublin Philosophical Magazine and J Sci. 1901;2(11):559–72.

Article  Google Scholar 

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.

Article  PubMed  PubMed Central  Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289–300.

Article  Google Scholar 

Bonferroni C. Teoria statistica delle classi e calcolo delle probabilita. Pubblicazioni del R Istituto Superiore di Scienze Economiche e Commericiali di Firenze. 1936;8:3–62.

Google Scholar 

Team RC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.

Google Scholar 

Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12(2):109–16.

Article  PubMed  CAS  Google Scholar 

Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437-52.e17.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol. 2005;119(3):219–44.

Article  PubMed  CAS  Google Scholar 

Monks A, Zhao Y, Hose C, Hamed H, Krushkal J, Fang J, et al. The NCI transcriptional pharmacodynamics workbench: a tool to examine dynamic expression profiling of therapeutic response in the NCI-60 cell line panel. Can Res. 2018;78(24):6807–17.

Article  CAS  Google Scholar 

Bush EC, Ray F, Alvarez MJ, Realubit R, Li H, Karan C, et al. PLATE-Seq for genome-wide regulatory network analysis of high-throughput screens. Nat Commun. 2017;8(1):105.

Article  PubMed  PubMed Central  Google Scholar 

Abelin JG, Patel J, Lu X, Feeney CM, Fagbami L, Creech AL, et al. Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes. Mol Cell Proteomics. 2016;15(5):1622–41.

Article  PubMed  PubMed Central  CAS